Novartis OTC Stock Widgets and Gadgets

NVSEF
 Stock
  

USD 84.85  0.84  1.00%   

Macroaxis provides equity-specific financial widgets, gadgets, and stock tickers for Novartis Ag Basl. These reusable financial scriptlets can be easily installed within any HTML-based document by an end user without requiring any additional resources. Macroaxis equity widgets for Novartis can be integrated to existing financial portals, investment related sites, business school online boards, or personal blogs. Novartis Ag Basl widgets and tickers can be used to distribute on-demand financial information including other stocks, funds, ETFs as well as world market quotes, changes, and fundamentals. This page provides just few examples of widgets and tickers designed for Novartis. Additionally, see Stocks Correlation.


Intraday Equity Chart   Quick Equity Feed
Equity Search   Quote Ticker   Widgets Data Sheet

Live Stock Ticker Example

Market Snapshot Widget Example

 DOW
 31,042 
USA 
  0.87 
 NYSE
 14,608 
USA 
  0.06 
 Nasdaq
 11,090 
USA 
  0.55 
 S&P 500
 3,816 
USA 
  0.80 
 NASDAQ UK
 920.90 
UK 
  -1.21 
 DAX
 12,813 
Germany 
  0.23 
 Shanghai
 3,388 
China 
  -0.32 
 Hang Seng
 21,860 
Hong Kong 
  -0.62 
 BSE
 52,908 
India 
  -0.21 
 IPC
 47,850 
Mexico 
  -0.44 
 CAC 40
 5,931 
France 
  0.14 
 Bovespa
 99,051 
Brazil 
  -0.57 
 Seoul Comp
 2,305 
South Korea 
  -1.17 
 Taiwan Wtd
 14,343 
Taiwan 
  -3.26 
 SPTSX Comp
 18,861 
Canada 
  0.0002 
 MerVal
 38,391 
Argentina 
  -56.44 
 NZSE
 10,753 
New Zealand 
  -1.06 
 ATX
 2,863 
Austria 
  -0.55 
 OSE All
 1,017 
Norway 
  -4.92 
 Bursa Malaysia
 1,450 
USA 
  0.38 
 Madrid Gnrl
 867.05 
Spain 
  1.22 
 Stockholm
 739.93 
Sweden 
  0.77 
 Swiss Mrt
 10,770 
Switzerland 
  0.27 
 Israel Index
 1,245 
Israel 
  -0.99 
 Jakarta Comp
 6,794 
Indonesia 
  -1.7 
 Straits Tms
 3,096 
Singapore 
  -0.21 
 All Ords
 6,720 
Australia 
  -0.39 
 ISEQ
 6,318 
Ireland 
  0.64 
 NIKKEI 225
 25,936 
Japan 
  -1.73 
 Russia TR
 0.00 
Russia 
  0.00 
 IBEX 35
 8,176 
Spain 
  0.96 
 NASDAQ Italy
 956.70 
Italy 
  -0.13 
 Greece TR
 506.99 
Greece 
  -1.4 
 OMX COPENHAGEN
 2,312 
Denmark 
  1.06 
 EURONEXT BEL-20
 3,708 
Belgium 
  0.71 
 AEX Amsterdam
 655.68 
Netherlands 
  -27.4 
 Russell 2000
 1,723 
USA 
  0.88 
 OMXVGI
 892.04 
Lithuania 
  0.11 
 NQFI
 1,464 
Finland 
  0.23 
 NQEGT
 905.58 
Egypt 
  -0.15 
 NQTH
 919.75 
Thailand 
  -0.38 
 OMXRGI
 1,141 
Latvia 
  1.09 
 NQPH
 850.42 
Philippine 
  0.0271 
 XU100
 2,444 
Turkey 
  1.60 

Investing Ideas

In addition to having Novartis in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas  

Compare Novartis

Compare Novartis To Peers

Additionally, see Stocks Correlation. Note that the Novartis Ag Basl information on this page should be used as a complementary analysis to other Novartis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Novartis OTC Stock analysis

When running Novartis Ag Basl price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Is Novartis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novartis. If investors know Novartis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novartis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.088
Market Capitalization
194.5 B
Quarterly Revenue Growth YOY
0.009
Return On Assets
0.0651
Return On Equity
0.43
The market value of Novartis Ag Basl is measured differently than its book value, which is the value of Novartis that is recorded on the company's balance sheet. Investors also form their own opinion of Novartis' value that differs from its market value or its book value, called intrinsic value, which is Novartis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novartis' market value can be influenced by many factors that don't directly affect Novartis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novartis' value and its price as these two are different measures arrived at by different means. Investors typically determine Novartis value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novartis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.